首页> 美国卫生研究院文献>Marine Drugs >Cognitive Impairment in Chronic Obstructive Pulmonary Disease (COPD): Possible Utility of Marine Bioactive Compounds
【2h】

Cognitive Impairment in Chronic Obstructive Pulmonary Disease (COPD): Possible Utility of Marine Bioactive Compounds

机译:慢性阻塞性肺疾病(COPD)的认知障碍:海洋生物活性化合物的可能效用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chronic obstructive pulmonary disease (COPD) is characterized by long-term airflow limitation. Early-onset COPD in non-smoker subjects is ≥60 years and in the elderly is often associated with different comorbidities. Cognitive impairment is one of the most common feature in patients with COPD, and is associated with COPD severity and comorbidities. Cognitive impairment in COPD enhances the assistance requirement in different aspects of daily living, treatment adherence, and effectual self-management.This review describes various bioactive compounds of natural marine sources that modulate different targets shared by both COPD and cognitive impairment and hypothesizes a possible link between these two syndromes.
机译:慢性阻塞性肺疾病(COPD)的特点是长期气流受限。非吸烟者的早发COPD≥60岁,而老年人通常伴随不同的合并症。认知障碍是COPD患者最常见的特征之一,并与COPD的严重程度和合并症相关。慢性阻塞性肺病的认知障碍提高了日常生活,治疗依从性和有效自我管理等各个方面的援助需求。这篇综述描述了天然海洋生物的各种生物活性化合物,它们调节了慢性阻塞性肺病和认知障碍所共有的不同目标,并推测了可能的联系在这两个综合症之间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号